Related references
Note: Only part of the references are listed.Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer
W. Fraser Symmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Effects of sample size on robustness and prediction accuracy of a prognostic gene signature
Seon-Young Kim
BMC BIOINFORMATICS (2009)
Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer
Alberto Calabro et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
Yi Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Coordinates in the Universe of Node-Negative Breast Cancer Revisited
Marcus Schmidt et al.
CANCER RESEARCH (2009)
Prediction of breast cancer metastasis by genomic profiling: where do we stand?
Ulrich Pfeffer et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Model-Based Prediction of Phase III Overall Survival in Colorectal Cancer on the Basis of Phase II Tumor Dynamics
Laurent Claret et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Can Survival Prediction Be Improved By Merging Gene Expression Data Sets?
Haleh Yasrebi et al.
PLOS ONE (2009)
Gene expression profiling of the tumor microenvironment during breast cancer progression
Xiao-Jun Ma et al.
BREAST CANCER RESEARCH (2009)
Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer
Mads Thomassen et al.
BMC CANCER (2008)
Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stability
Martin H. van Vliet et al.
BMC GENOMICS (2008)
A gene sets approach for identifying prognostic gene signatures for outcome prediction
Seon-Young Kim et al.
BMC GENOMICS (2008)
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Sherene Loi et al.
BMC GENOMICS (2008)
The humoral immune system has a key prognostic impact in node-negative breast cancer
Marcus Schmidt et al.
CANCER RESEARCH (2008)
Development of the 21-gene assay and its application in clinical practice and clinical trials
Joseph A. Sparano et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Clinical application of the 70-gene profile: The MINDACT trial
Fatima Cardoso et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak et al.
NATURE MEDICINE (2008)
A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer
Fabien Reyal et al.
BREAST CANCER RESEARCH (2008)
被撤回的出版物: Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer (Retracted article. See vol. 28, pg. 5229, 2010)
David S. Hsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer
Jack X. Yu et al.
BMC CANCER (2007)
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2007)
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
被撤回的出版物: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial (Retracted Article. See vol 12, pg 116, 2011)
[Anonymous]
LANCET ONCOLOGY (2007)
Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen
Soonmyung Paik
ONCOLOGIST (2007)
被撤回的出版物: Genomic signatures to guide the use of chemotherapeutics (Retracted article. See vol. 17, pg. 135, 2011)
Anil Potti et al.
NATURE MEDICINE (2006)
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
Marc Buyse et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
被撤回的出版物: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer (Retracted Article. See vol 356, pg 201, 2007)
Anil Potti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer
L Ein-Dor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
A consensus prognostic gene expression classifier for ER positive breast cancer
Andrew E. Teschendorff et al.
GENOME BIOLOGY (2006)
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
LD Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Prediction of cancer outcome with microarrays: a multiple random validation strategy
S Michiels et al.
LANCET (2005)
Long-term survival rates of laryngeal cancer patients treated by radiation and surgery, radiation alone, and surgery alone : studied by lognormal and Kaplan-Meier survival methods
P Tai et al.
BMC CANCER (2005)
Outcome signature genes in breast cancer: is there a unique set?
L Ein-Dor et al.
BIOINFORMATICS (2005)
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Y Pawitan et al.
BREAST CANCER RESEARCH (2005)
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data
MH Dai et al.
NUCLEIC ACIDS RESEARCH (2005)
Gene expression signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds
HY Chang et al.
PLOS BIOLOGY (2004)
Estrogen receptor α signaling in inflammatory leukocytes is dispensable for 17β-estradiol-mediated inhibition of experimental autoimmune encephalomyelitis
L Garidou et al.
JOURNAL OF IMMUNOLOGY (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
